AI Article Synopsis
- The study aimed to evaluate how adding ketorolac to a standard antibiotic-steroid treatment affects vision-related quality of life for cataract surgery patients.
- Patients were divided into two groups: one received only the standard treatment, while the other received the same treatment plus ketorolac, with their visual function assessed using the VFQ-25 questionnaire.
- Results showed no significant improvements in vision-related quality of life from adding ketorolac to the treatment, indicating it might not provide extra benefits.
Article Abstract
Introduction: The purpose of our study was to investigate the impact of ketorolac addition to the well-established combination of antibiotic-steroid agent in terms of vision-related quality of life.
Methods: Patients were randomized to: (1) fixed combination of tobramycin 0.3%-dexamethasone 0.1%, one drop qid (n = 68) and (2) fixed combination of tobramycin 0.3%-dexamethasone 0.1%, one drop qid, plus ketorolac tromethamine 0.5%, one drop tid (n = 70). All patients completed the VFQ-25 questionnaire to assess their functional vision before cataract surgery and postoperatively on days 7, 28 and 42. The statistical analysis comprised the point-wise comparison between the two groups at the four time points for all sub-scales of the VFQ-25 questionnaire, as well as the composite score.
Results: No significant differences were noted regarding the composite score, as well as all subscales in all examined time points.
Conclusions: The addition of ketorolac did not seem to offer any additional benefit in terms of vision-related quality of life.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449292 | PMC |
| http://dx.doi.org/10.1007/s40123-016-0073-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!